Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT-Reference-Cited by-同舟云学术

Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Published:2017-01 Issue:1 Volume:23 Page:44-52
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Heidenreich Silke,Ziagkos Dimitris,de Wreede Liesbeth C.,van Biezen Anja,Finke Jürgen,Platzbecker Uwe,Niederwieser Dietger,Einsele Hermann,Bethge Wolfgang,Schleuning Michael,Beelen Dietrich W.,Tischer Johanna,Nagler Arnon,Glass Bertram,Maertens Johan,Yáñez Lucrecia,Beguin Yves,Sill Heinz,Scheid Christof,Stelljes Matthias,Ganser Arnold,Zachée Pierre,Selleslag Dominik,de Witte Theo,Robin Marie,Kröger Nicolaus

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. No increase in age-specific incidence of myelodysplastic syndromes;Germing;Haematologica,2004

2. Incidence of myelodysplastic syndromes in a Swedish population;Radlund;Eur J Haematol,1995

4. Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry;Neukirchen;Leuk Res,2011

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

2. Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation;Cancers;2024-01-25

3. Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT;American Journal of Hematology;2023-11-27

4. Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome;Bone Marrow Transplantation;2023-11-03

5. Correspondence;Deutsches Ärzteblatt international;2023-09-15